Cidara Therapeutics, Inc.
BalancedCDTX·US·🇺🇸 US
49%buys·51%sells
420 transactions$410.0MTotal buys·38 buys
$2.6MTotal sells·40 sells
4343 insiders
Last: Dec 29, 2025
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Dec 29, 25 | Davarpanah Nicole Negar | Gift | - | |
| Dec 22, 25 | Stein Jeffrey | Gift | - | |
| Dec 19, 25 | Stein Jeffrey | Gift | - | |
| Dec 19, 25 | Stein Jeffrey | Gift | - | |
| Dec 17, 25 | Stein Jeffrey | Gift | - | |
| Dec 17, 25 | Stein Jeffrey | Gift | - | |
| Dec 10, 25 | Ward Shane | Exercise | - | |
| Dec 10, 25 | Ward Shane | Exercise | - | |
| Dec 10, 25 | Davarpanah Nicole Negar | Other | $2.3M | |
| Dec 10, 25 | Ward Shane | Exercise | $130K |
Cidara Therapeutics, Inc. (CDTX) has recorded 420 insider transactions from 43 insiders. Total insider buying volume stands at $410.0M, while total selling volume is $2.6M. Insider activity shows a balanced mix of buying and selling.
Cidara Therapeutics, Inc. (CDTX) has recorded 420 insider operations, including 38 open-market purchases ($410.0M), 40 sales ($2.6M) and 342 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is balanced.
Cidara Therapeutics, Inc. shows moderate insider activity with 7 active months out of the last 12, typical of a company whose trading windows are concentrated around financial disclosures.
Among the most active insiders are Stein Jeffrey (CEO), KARBE FRANK (CFO) & Onaitis Matthew (CFO), with respectively 95, 126, 69 transactions.
Across all 420 recorded transactions, the breakdown by type is: grant (237, 56%), exercise (78, 19%), sells (40, 10%), buys (38, 9%), gift (10, 2%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Cidara Therapeutics, Inc. has recorded 420 insider operations in total, including 38 open-market purchases ($410.0M), 40 sales ($2.6M) and 342 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on December 29, 2025.
Insiders at Cidara Therapeutics, Inc. show balanced activity with 49% purchases and 51% sales. Total buy volume is $410.0M versus $2.6M in sales.
InsiderLens tracks 43 insiders at Cidara Therapeutics, Inc. (CDTX). Stein Jeffrey (CEO, 95 tx), KARBE FRANK (CFO, 126 tx), Onaitis Matthew (CFO, 69 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for CDTX is neutral, based on a 49% buy ratio across 78 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Cidara Therapeutics, Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.